These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 11085972

  • 21. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study.
    Singh S, Zoble RG, Yellen L, Brodsky MA, Feld GK, Berk M, Billing CB.
    Circulation; 2000 Nov 07; 102(19):2385-90. PubMed ID: 11067793
    [Abstract] [Full Text] [Related]

  • 22. Effects of intravenous dofetilide on induction of atrioventricular re-entrant tachycardia.
    Cobbe SM, Campbell RW, Camm AJ, Nathan AW, Rowland E, Bloch-Thomsen PE, Møller M, Jordaens L.
    Heart; 2001 Nov 07; 86(5):522-6. PubMed ID: 11602544
    [Abstract] [Full Text] [Related]

  • 23. Dofetilide. UK 68, UK 68798, Tikosyn, Xelide.
    Drugs R D; 1999 Apr 07; 1(4):304-11. PubMed ID: 10566050
    [No Abstract] [Full Text] [Related]

  • 24. Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.
    Coleman CI, Sood N, Chawla D, Talati R, Ghatak A, Kluger J, Dofetilide and Intravenous Magnesium Evaluation (DIME) Investigators.
    Europace; 2009 Jul 07; 11(7):892-5. PubMed ID: 19351630
    [Abstract] [Full Text] [Related]

  • 25. The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock.
    Mehdirad AA, Carnes CA, Nelson SD.
    Pacing Clin Electrophysiol; 1999 Jan 07; 22(1 Pt 2):147-51. PubMed ID: 9990620
    [Abstract] [Full Text] [Related]

  • 26. Dofetilide for atrial fibrillation.
    Med Lett Drugs Ther; 2000 May 15; 42(1078):41-2. PubMed ID: 10847114
    [No Abstract] [Full Text] [Related]

  • 27. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
    Banchs JE, Baquero GA, Nickolaus MJ, Wolbrette DL, Kelleman JJ, Samii S, Grando-Ting J, Penny-Peterson E, Davidson WR, Young SK, Naccarelli GV, Gonzalez MD.
    Congenit Heart Dis; 2014 May 15; 9(3):221-7. PubMed ID: 23947935
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dofetilide dose reductions and discontinuations in women compared with men.
    Pokorney SD, Yen DC, Campbell KB, Allen LaPointe NM, Sheng S, Thomas L, Bahnson TD, Daubert JP, Picini JP, Jackson KP, Thomas KL, Al-Khatib SM.
    Heart Rhythm; 2018 Apr 15; 15(4):478-484. PubMed ID: 29605013
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of the effects of IK,ACh, IKr, and INa block in conscious dogs with atrial fibrillation and on action potentials in remodeled atrial trabeculae.
    Juhász V, Hornyik T, Benák A, Nagy N, Husti Z, Pap R, Sághy L, Virág L, Varró A, Baczkó I.
    Can J Physiol Pharmacol; 2018 Jan 15; 96(1):18-25. PubMed ID: 28892643
    [Abstract] [Full Text] [Related]

  • 33. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.
    J Cardiovasc Electrophysiol; 2012 Mar 15; 23(3):296-301. PubMed ID: 21955243
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Update of the clinical impact and issues surrounding Dofetilide (Tikosyn) therapy.
    Friedman L, Alexander E.
    AACN Adv Crit Care; 2006 Mar 15; 17(2):102-8; quiz 109-110. PubMed ID: 16767008
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Electrophysiologic and antiarrhythmic effects of the new class III antiarrhythmic drug KCB-328 in experimental canine atrial flutter.
    Rahme MM, Ungab GA, Wadhwa M, Al-Kandari F, Yao B, Gupta A, Lee K, Kim HY, Feld GK.
    J Cardiovasc Pharmacol Ther; 2001 Jul 15; 6(3):297-306. PubMed ID: 11584336
    [Abstract] [Full Text] [Related]

  • 39. Amiodarone and atrial fibrillation.
    London B.
    J Cardiovasc Electrophysiol; 2007 Dec 15; 18(12):1321-2. PubMed ID: 17971150
    [No Abstract] [Full Text] [Related]

  • 40. Pure class III antiarrhythmic drugs: focus on dofetilide.
    Doshi SK, Singh BN.
    J Cardiovasc Pharmacol Ther; 2000 Oct 15; 5(4):237-47. PubMed ID: 11150393
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.